Los Angeles Capital Management LLC bought a new stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON – Free Report) in the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor bought 1,774 shares of the biotechnology company’s stock, valued at approximately $709,000.
Other large investors also recently modified their holdings of the company. Empowered Funds LLC bought a new stake in shares of Axon Enterprise in the first quarter valued at $340,000. M&G Plc purchased a new stake in shares of Axon Enterprise during the 1st quarter valued at approximately $12,312,000. Vanguard Group Inc. boosted its holdings in Axon Enterprise by 2.7% in the 1st quarter. Vanguard Group Inc. now owns 8,143,306 shares of the biotechnology company’s stock worth $2,547,878,000 after buying an additional 212,401 shares during the period. Acadian Asset Management LLC bought a new position in Axon Enterprise in the 1st quarter worth approximately $2,137,000. Finally, Edgestream Partners L.P. purchased a new stake in shares of Axon Enterprise during the first quarter worth $1,043,000. Hedge funds and other institutional investors own 79.08% of the company’s stock.
Axon Enterprise Price Performance
Axon Enterprise stock opened at $599.35 on Friday. Axon Enterprise, Inc. has a 52-week low of $220.78 and a 52-week high of $624.84. The company has a quick ratio of 2.63, a current ratio of 2.96 and a debt-to-equity ratio of 0.32. The firm’s fifty day moving average is $438.79 and its 200 day moving average is $357.27. The company has a market cap of $45.70 billion, a price-to-earnings ratio of 154.87, a PEG ratio of 15.10 and a beta of 0.94.
Insider Activity at Axon Enterprise
Wall Street Analysts Forecast Growth
Several equities analysts have recently weighed in on AXON shares. Needham & Company LLC lifted their price target on Axon Enterprise from $525.00 to $600.00 and gave the company a “buy” rating in a research report on Friday, November 8th. Barclays increased their price target on shares of Axon Enterprise from $381.00 to $387.00 and gave the stock an “overweight” rating in a report on Wednesday, August 7th. The Goldman Sachs Group boosted their price objective on shares of Axon Enterprise from $385.00 to $441.00 and gave the company a “buy” rating in a research note on Wednesday, October 23rd. Northland Securities upped their target price on Axon Enterprise from $365.00 to $550.00 and gave the stock an “outperform” rating in a research note on Monday, November 11th. Finally, Craig Hallum raised their price objective on shares of Axon Enterprise from $370.00 to $376.00 and gave the company a “buy” rating in a research report on Wednesday, August 7th. Two equities research analysts have rated the stock with a hold rating and twelve have assigned a buy rating to the stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $427.83.
View Our Latest Stock Analysis on Axon Enterprise
Axon Enterprise Company Profile
Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.
Further Reading
- Five stocks we like better than Axon Enterprise
- What is a Dividend King?
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- With Risk Tolerance, One Size Does Not Fit All
- Top-Performing Non-Leveraged ETFs This Year
- Stock Market Upgrades: What Are They?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Want to see what other hedge funds are holding AXON? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Axon Enterprise, Inc. (NASDAQ:AXON – Free Report).
Receive News & Ratings for Axon Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Axon Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.